A recent lawsuit filed by Myriad Genetics involving the alleged infringement of their controversial breast cancer screening tool has included the prestigious Toronto SickKids hospital as a co-plaintiff. This lawsuit…
Tag: gene patents
Isolated Genes Are None Of Your Business! – SCOTUS Decides Myriad
On June 13, 2013, the U.S. Supreme Court rendered a decision which ruled against the patenting of isolated DNA sequences in their natural form in the now infamous case involving Myriad Genetics, Inc.…
in Access to Medicines, Competition, Human Rights, IP, Patent Practice, Patentability, Patents1by Editor
872
The ‘Myriad’ with the Golden ‘Gene’: Australia Upholds Breast Cancer Gene Patents
The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad…
in Blogs, Commercialization, Competition, European Union, Human Rights, Innovation, Patent Practice, Patentability, Patents, Regulatory Policy, Trade Secrets, US2by Editor
2835
Live and Let Die: Gene Patenting Plot Thickens as the Patent/Trade Secret Line is Blurred
The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer has been well-documented in the…
U.S. Court of Appeals Stands Tall on the Subject of Gene Patents in the Wake of the Mayo v Prometheus Ruling
The United States Court of Appeals for the Federal Circuit, in the case Association for Molecular Pathology (AMP) and ACLU v. USPTO and Myriad Genetics (Myriad), held in August that…
BRCA Gene Patents Lawsuit Lives On
George Nathanael is a JD Candidate at Osgoode Hall Law School. Earlier this month a United States District Court denied a motion to dismiss a lawsuit brought forth against the…